Bradford T Whitmore

Director Bradford T Whitmore bought 108,878 shares at blended $6.57 over 3 days; 5.6% portfolio increase amid unprofitable operations.

Director Bradford T Whitmore executed three separate purchases totaling 108,878 shares for $715,313.54 between 2026-05-21 and 2026-05-26, raising his holdings from 1,941,759 to 2,050,637 shares. The company's latest quarterly financials show revenue of $47,445,000.00 against net income of -$451,000.00, with annual revenue growth of +16.2% but full-year profitability still negative. At his prior trades at ULBI, 4 of 5 buys were well-timed at the 90-day mark, suggesting pattern recognition in his purchase timing at this ticker. The current stock price of $6.86 sits 27.9% below the 52-week high of $9.52 and down 9.1% over the past 30 days, though up 16.6% over 90 days—positioning this purchase in the context of recent price volatility and moderate-term gains.

Director WHITMORE BRADFORD T purchased 187,512 shares across 3 transactions (Mar 12–16) for $1,196,908.98; blended avg $6.38; holdings now 1,941,759 shares (+10.7%).

Director Whitmore Bradford T executed 3 separate purchases totaling 187,512 shares for $1,196,908.98 between March 12–16, 2026, increasing his holdings by 10.7% to 1,941,759 shares. The blended average purchase price of $6.38 sits below the current price of $7.01, representing a near-term gain on the position. His prior trades at ULBI show 4 of 5 prior buys were well-timed at the 90-day mark, suggesting a pattern of entering at favorable inflection points. However, fundamentals warrant caution: the company posted net income of $-1,220,000.00 on quarterly revenue of $43,371,000.00, carries a P/E of 70.10, and has grown annual revenue only 3.7% year-over-year, indicating a loss-making business trading at a stretched valuation. The transaction's significance lies in the scale of capital deployed ($1.2M) and the insider's demonstrated timing skill at this ticker, offsetby the company's unprofitable status and elevated multiple.

Director Whitmore purchases 53,000 shares (53.0K) over 3 days at $5.68 avg; holdings rise to 1.24M shares (+4.5%)

Director Bradford T Whitmore executed 3 separate purchases totaling 53,000 shares for $300,902.22 between December 12–16, 2025, at prices ranging from $5.63 to $5.70 (blended average $5.68). His post-transaction holdings reached 1,235,631 shares, representing a 4.5% increase. At the current price of $5.79, the stock trades 36.6% below its 52-week high of $9.13, though up 4.1% over 30 days. His prior 4 measurable purchases at ULBI showed 0 of 4 well-timed at the 90-day mark, with outcomes ranging from -23.7% to -9.0% on the 90-day view. The company posted net income of $-1.2M in the latest quarter on $43.4M revenue, with a P/E of 57.90. This is a routine accumulation by a board member without scheduled trading plan disclosure, but the timing pattern at this ticker historically underperformed the broader market on 90-day horizons.

Director WHITMORE BRADFORD T bought 53,900 shares of ULBI at $4.97 on 2025-11-19; stock now $5.24, down 42.6% from 52-week high.

WHITMORE BRADFORD T purchased 53,900 shares at $4.97, increasing his position from 1,128,731 to 1,182,631 shares. The transaction occurred as ULBI trades near multi-month lows, down 21.2% over 30 days and 27.3% over 90 days from recent price levels. His prior trading activity at ULBI shows mixed timing outcomes: of five recent open-market purchases at this ticker, only one demonstrated a positive 90-day return, with the most recent three buys (August 19–21, 2025) each followed by 90-day declines ranging from 15.6% to 23.7%. The company reports a net loss of $1.2M on quarterly revenue of $43.4M, with a P/E ratio of 52.40, reflecting elevated valuation despite recent operational challenges. This purchase follows a pattern of accumulation during periods of weakness but does not yet demonstrate successful market timing specific to ULBI.

Director WHITMORE BRADFORD T purchased 58.7K shares (3 transactions) at blended $6.60 on Aug 19–21, raising stake 5.5%.

Director Whitmore Bradford T executed 3 separate purchases totaling 58,664 shares for $387,100.07 between August 19 and August 21, 2025, at prices ranging from $6.56 to $6.63 (blended average $6.60). This raises his post-transaction holdings to 1,128,731 shares, a +5.5% increase. The purchases occur during a period of stock weakness: the current price of $6.66 sits -40.4% below the 52-week high and -26.9% over 30 days. Notably, his prior 4 measurable buys at ULBI have all exhibited positive 90-day returns (ranging from +12.8% to +50.4%), establishing a ticker-specific pattern of well-timed accumulation. This multi-transaction filing does not indicate a single impulsive decision but a deliberate accumulation at depressed levels.

Director WHITMORE BRADFORD T buys 10,000 ULBI shares at $7.64 on 2025-06-13; stock now $7.74, up 40.2% in 30 days from depressed valuation.

Director Whitmore Bradford T purchased 10,000 shares of ULBI at $7.64, increasing his holdings to 1,070,067 shares. The stock's current price of $7.74 reflects a recent sharp recovery: +40.2% over 30 days and +40.3% over 90 days, though it remains 35.4% below its 52-week high of $11.98. This buy follows four other ULBI purchases within the prior month (2025-05-13 through 2025-05-23), indicating sustained accumulation at current price levels. Across his broader trading history, Whitmore's prior 18 open-market buys have averaged +379.5% return over 30 days and +509.8% over 90 days with an 87.50% win rate—though at ULBI specifically, measurable 90-day outcomes from recent purchases remain incomplete. ULBI's fundamentals show revenue of $50.7M, net income of $1.9M, and a P/E of 24.19; annual revenue growth of +3.7% suggests modest operational momentum. The timing of this purchase coincides with ULBI's recovery phase after a significant drawdown from its 52-week peak.

WHITMORE (10% Owner) simultaneously bought 6,689,000 shares for $28,093,800.00 and sold 6,689,000 shares for $28,093,800.00 at $4.20

WHITMORE BRADFORD T executed 2 purchases totaling 6,689,000 shares for $28,093,800.00 and 2 simultaneous sales totaling 6,689,000 shares for $28,093,800.00—both at identical prices ($4.20) on the same date. This 1:1 matched buy-sell is unusual and warrants inquiry into its purpose: whether it represents a tax-driven transaction, a position restructuring, an exercise or rehedging, or a regulatory filing artifact. The insider remains a substantial 10% owner with 18,669,879 shares post-transaction, and the stock has rallied +28.8% in the past 30 days from a depressed prior level, trading at 52-week highs near $4.15. The company shows strong growth (+40.4% annual revenue) on a modest $14.6M quarterly revenue base, though valuations remain compressed at P/E 80.60.

Director WHITMORE BRADFORD T bought 11,980 shares of ULBI at $5.41 on 2025-05-23; 2 other insiders also bought within 14 days (cluster pattern).

WHITMORE BRADFORD T, a director, purchased 11,980 shares at $5.41, adding to existing holdings of 1,048,087 shares, as part of a three-insider buying cluster over a 14-day window. His prior trades at ULBI show a 2 of 2 well-timed pattern at the 90-day mark, with purchases on 2023-12-08 and 2023-12-06 posting +35.6% and +37.4% returns respectively, though the two most recent ULBI trades (2025-05-15 and 2025-05-14) remain outcome-unmeasurable. Cross-ticker, his open-market history across all holdings spans 20 prior buys with an average 90-day return of +709.5% and a 76.92% win rate. The current price of $6.80 represents -43.6% from the 52-week high but +51.4% over the past 30 days, showing volatile recovery from depressed levels. With a P/E of 21.25, market cap of $113,104,162.00, and latest quarterly revenue of $50,746,000.00, the company remains operationally stable, though annual revenue growth of +3.7% is modest.

Director Whitmore buys 27,160 shares at blended avg $5.47 across 3 transactions; director position now 1,048,087 shares (+2.7%)

WHITMORE BRADFORD T, Director at ULTRALIFE CORP, executed 3 separate purchases totaling 27,160 shares for $148,475.44, with a blended average price of $5.47 per share across May 13–15, 2025. His prior 5 purchases at ULBI (all in late November–early December 2023) were well-timed at the 90-day mark, averaging +30.4% returns over that horizon, suggesting a track record of entering at levels that subsequently appreciate. In this filing's cluster context, 3 other insiders also bought within the past 14 days, indicating coordinated insider accumulation at the current price level. Against a current price of $5.92 (up 34.2% over 30 days but down 17.3% over 90 days from the transaction window), the director's post-transaction holding of 1,048,087 shares represents a modest 2.7% increase versus his pre-transaction position of 1,020,927 shares. The timing and pattern align with his historical behavior at this ticker, but the modest size of this purchase relative to his existing position and the compressed price action post-filing suggest incremental accumulation rather than material position escalation.